Top US markets regulator probing insider trading guardrails, official says [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
and other firms have strong enough policies to ensure nonpublic information is not misused to gain an illegal edge in trading, a top official told Reuters. The SEC is looking to crack down on ineffective policies and procedures as part of broader insider trading scrutiny, Gurbir Grewal, the SEC's enforcement director, said in a recent interview. "The frustration with insider trading is that sometimes the threat of jail and penalties don't prevent it," Grewal said. "So we have to emphasize the tools we have and the firms need to tighten up their policies to prevent abuse." The SEC's efforts are aimed not just at insider trading in equity markets, but also potential use of complex financial tools including swaps or derivatives to benefit from non-public information or to mask misconduct, he said. Grewal declined to say whether the agency has or would launch an enforcement sweep to target the issue. Under Democratic leadership, the SEC has pursued theories of insider trading se
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer [Yahoo! Finance]Yahoo! Finance
- FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerBusiness Wire
- Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? [Seeking Alpha]Seeking Alpha
- J&J, Bristol Myers lose challenges to US drug price negotiation program [Reuters]Reuters
- UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/29/24 - Form 8-K
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- PFE's page on the SEC website